OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Earlier this week, he unveiled perhaps the most ambitious infrastructure project in history—and all but dedicated it to Sam ...
Stargate is little more than an extension of Sam Altman's powerful AI company, anonymous sources told the Financial Times.
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in ...
Sam Altman, CEO of OpenAI, announced that AGI has not yet been achieved and the company plans to release new developments next month. He cautioned against high expectations fueled by social ...
An icon in the shape of a lightning bolt. Impact Link Over the years, OpenAI CEO Sam Altman has shared predictions about where he thinks we're headed on artificial general intelligence ...